Circulating cell-free DNA is associated with cardiometabolic risk factors: The Health 2000 Survey

Atherosclerosis

Volumn 233, Issue 1, 2014, Pages 268-271

  Jylhävä, Juulia ^a   Lehtimäki, Terho ^a   Jula, Antti ^b   Moilanen, Leena ^c   Kesäniemi, Y Antero ^d,e   Nieminen, Markku S ^f   Kähönen, Mika ^a,g   Hurme, Mikko ^a,h  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF OULU   (Finland)

^e OULU UNIVERSITY HOSPITAL   (Finland)

^f HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^g TAMPERE UNIVERSITY HOSPITAL   (Finland)

^h FIMLAB LABORATORIES   (Finland)

Author keywords

Arterial stiffness; Biomarker; Cardiometabolic risk; Cf DNA; Early atherosclerosis

Indexed keywords

ARTERIAL STIFFNESS; BIOMARKER; CARDIOMETABOLIC RISK; CF-DNA; EARLY ATHEROSCLEROSIS;

AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; DNA; ELASTIC MODULUS; ELASTICITY; ESTROGEN REPLACEMENT THERAPY; FEMALE; FINLAND; GLUCOSE INTOLERANCE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; VASCULAR STIFFNESS;

EID: 84893876222     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.12.022     Document Type: Article

References (25)

1. Ziegler A., Zangemeister-Wittke U., Stahel R.A. Circulating DNA: a new diagnostic gold mine?. Cancer Treat Rev 2002, 28:255-271.
2. Butt A.N., Swaminathan R. Overview of circulating nucleic acids in plasma/serum. Ann N Y Acad Sci 2008, 1137:236-242.
3. Antonatos D., Patsilinakos S., Spanodimos S., Korkonikitas P., Tsigas D. Cell-free DNA levels as a prognostic marker in acute myocardial infarction. Ann N Y Acad Sci 2006, 1075:278-281.
4. Shimony A., Zahger D., Gilutz H., et al. Cell free DNA detected by a novel method in acute ST-elevation myocardial infarction patients. Acute Card Care 2010, 12:109-111.
5. Cui M., Fan M., Jing R., et al. Cell-free circulating DNA: a new biomarker for the acute coronary syndrome. Cardiology 2013, 124:76-84.
6. Rainer T.H., Chan A.K., Lee L.L., et al. Use of plasma DNA to predict mortality and need for intensive care in patients with abdominal pain. Clin Chim Acta 2008, 398:113-117.
7. Chang C.P., Chia R.H., Wu T.L., Tsao K.C., Sun C.F., Wu J.T. Elevated cell-free serum DNA detected in patients with myocardial infarction. Clin Chim Acta 2003, 327:95-101.
8. Jing R.R., Wang H.M., Cui M., et al. Asensitive method to quantify human cell-free circulating DNA in blood: relevance to myocardial infarction screening. Clin Biochem 2011, 44:1074-1079.
9. Jylhava J., Jylha M., Lehtimaki T., Hervonen A., Hurme M. Circulating cell-free DNA is associated with mortality and inflammatory markers in nonagenarians: the Vitality 90+ Study. Exp Gerontol 2012, 47:372-378.
10. Jylhava J., Nevalainen T., Marttila S., Jylha M., Hervonen A., Hurme M. Characterization of the role of distinct plasma cell-free DNA species in age- associated inflammation and frailty. Aging Cell 2013, 12:388-397.
11. Aromaa A., Koskinen S. Health and functional capacity in Finland. Baseline results of the Health 2000 Health Examination Survey 2004, National Public Health Institute, Helsinki. N.P.H. Institute (Ed.).
12. Sipila K., Kahonen M., Salomaa V., et al. Carotid artery intima-media thickness and elasticity in relation to glucose tolerance. Acta Diabetol 2012, 49:215-223.
13. Malo E., Ukkola O., Jokela M., et al. Resistin is an indicator of the metabolic syndrome according to five different definitions in the Finnish Health 2000 survey. Metab Syndr Relat Disord 2011, 9:203-210.
14. Sipila K., Moilanen L., Nieminen T., et al. Metabolic syndrome and carotid intima media thickness in the Health 2000 Survey. Atherosclerosis 2009, 204:276-281.
15. Reslan O.M., Khalil R.A. Vascular effects of estrogenic menopausal hormone therapy. Rev Recent Clin Trials 2012, 7:47-70.
16. Salomaa V., Riley W., Kark J.D., Nardo C., Folsom A.R. Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes. The ARIC Study. Atherosclerosis Risk in Communities Study. Circulation 1995, 91:1432-1443.
17. Gupta A.K., Joshi M.B., Philippova M., et al. Activated endothelial cells induce neutrophil extracellular traps and are susceptible to NETosis-mediated cell death. FEBS Lett 2010, 584:3193-3197.
18. Kawamoto R., Tomita H., Ohtsuka N., Inoue A., Kamitani A. Metabolic syndrome, diabetes and subclinical atherosclerosis as assessed by carotid intima-media thickness. JAtheroscler Thromb 2007, 14:78-85.
19. Civera M., Urios A., Garcia-Torres M.L., et al. Relationship between insulin resistance, inflammation and liver cell apoptosis in patients with severe obesity. Diabetes Metab Res Rev 2010, 26:187-192.
20. Ferreira D.M., Castro R.E., Machado M.V., et al. Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease. Diabetologia 2011, 54:1788-1798.
21. Garcia-Monzon C., Lo Iacono O., Mayoral R., et al. Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C. JHepatol 2011, 54:142-152.
22. Molloy E.J., O'Neill A.J., Grantham J.J., et al. Sex-specific alterations in neutrophil apoptosis: the role of estradiol and progesterone. Blood 2003, 102:2653-2659.
23. Kerksick C., Taylor L., Harvey A., Willoughby D. Gender-related differences in muscle injury, oxidative stress, and apoptosis. Med Sci Sports Exerc 2008, 40:1772-1780.
24. Jung J.Y., Roh K.H., Jeong Y.J., et al. Estradiol protects PC12 cells against CoCl2-induced apoptosis. Brain Res Bull 2008, 76:579-585.
25. Lopez-Ruiz A., Sartori-Valinotti J., Yanes L.L., Iliescu R., Reckelhoff J.F. Sex differences in control of blood pressure: role of oxidative stress in hypertension in females. Am J Physiol Heart Circ Physiol 2008, 295:H466-H474.